A randomized placebo-controlled clinical trial of docosahexaenoic acid (DHA) supplementation for X-linked retinitis pigmentosa.
Birch
David G
DG
The Retina Foundation of the Southwest and the Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
D019587:Dietary Supplements; D004281:Docosahexaenoic Acids / Q000627:therapeutic use*; D040181:Genetic Diseases, X-Linked / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012174:Retinitis Pigmentosa / Q000188:drug therapy* / Q000235:genetics
D004281:Docosahexaenoic Acids